Variations in biochemical parameters of Heterocapsa sp. and Olisthodiscus luteus grown in 12:12 light:dark cycles II. Changes in pigment composition

Hydrobiologia ◽  
1992 ◽  
Vol 238 (1) ◽  
pp. 149-157 ◽  
Author(s):  
Mikel Latasa ◽  
Elisa Berdalet ◽  
Marta Estrada
Keyword(s):  
Biochemical Parameters ◽  
Pigment Composition ◽  
Olisthodiscus Luteus

scholarly journals ANALYSIS OF THE PIGMENT STATUS OF SOME SPECIES OF GENUS ACER L. USING THE PROGRAM STATISTICA

2020 ◽  
Author(s):  
I.N. Turbina ◽  
◽  
G.M. Kukurichkin ◽  
Keyword(s):  
Biochemical Parameters ◽  
Physiological Status ◽  
Winter Period ◽  
Test Results ◽  
Plant Leaves ◽  
Pigment Composition ◽  
Summer Period ◽  
Protective Function ◽  
Adaptation Mechanisms ◽  
Pigment Complex

The present paper is aimed at the analysis of adaptation mechanisms of five species of the genus Acer L. in the culture of the botanical garden.With this view we studied the indices of the pigment complex (nitrogen balance - Nbi, flavonols - Flv and chlorophyll - Ch) in the assimilating organs of plants. It was revealed that the pigment composition of plant leaves indicates their relatively high physiological status. An increase in biochemical parameters (Nbi,Chl, Flv) was identified by the end of summer in comparison with the beginning of summer period, which testifies to the formation of the protective function of the plant in the pre-winter period. The following statistical methods were used for test results interpretation: Shapiro – Wilk tests, Mann – Whitney, Wilcoxon, Kruskal-Wallisand criteria.

Serum biochemical parameters in piglets after the application of essential oils

Planta Medica ◽  
2007 ◽  
Vol 73 (09) ◽  
Author(s):  
J Poracova ◽  
I Salamon ◽  
B Taylorova ◽  
M Zahatnanska ◽  
I Sutiakova
Keyword(s):  
Essential Oils ◽  
Biochemical Parameters ◽  
Serum Biochemical Parameters ◽  
Serum Biochemical

Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers

2020 ◽  
pp. 82-94
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Pharmaceutical Care ◽  
Biochemical Parameters ◽  
Positive Impact ◽  
Potential Effect ◽  
Care Group ◽  
Mineral Bone Disorder ◽  
Bone Disorder

Objective: the present study was aimed to evaluate the role of pharmaceutical services in improving the outcome of mineral bone disorder in patients with advanced chronic kidney disease. Methodology: One hundred and twenty patients with chronic kidney disease-mineral bone disorder (CKD-MBD) screened for eligibility, seventy-six patients enrolled in the study and randomly allocated into two groups: pharmaceutical care and usual care, both groups interviewed by the pharmacist using specific questionnaire for assessing the quality of life (QoL). All the drug related problems (DRPs) including drug-drug interactions (DDIs) were recorded by the pharmacist. Blood samples were collected and utilized for analyzing the levels of vitamin D, phosphorous, calcium, albumin and parathyroid hormone at baseline and three months after. The pharmaceutical care group received all the educations about their medications and how to minimize DRPs; improve the QoL. Additionally, the pharmaceutical intervention included correcting the biochemical parameters. Results: Pharmaceutical care significantly improved patients QoL and minimized DRPs and DDIs. It was also effective in improving the biochemical parameters. Conclusion: Pharmaceutical care has a positive impact on improving the outcome of patients with CKD-MBD through attenuating DRPs, improving the biochemical parameters and the QoL.

Sign in / Sign up

Export Citation Format

Share Document